IDEX Biometrics ASA IDXAF

IDEX Biometrics ASA, in collaboration with Hitachi Payment Services and Airtel Payments Bank, has launched India's first RuPay biometric payment card at the Global Fintech Fest. This innovative card utilizes biometric technology to enhance security and streamline payment processes, marking a significant advancement in the Indian payment landscape. The launch of the biometric payment card represents a major strategic move that could significantly alter IDEX Biometrics' competitive position and investor sentiment in the fintech sector.

IDEX Biometrics ASA has received approval for its prospectus as of September 29, 2025, which is a significant step in its regulatory compliance and future fundraising efforts. Approval of the prospectus is a major strategic move that could enhance the company's financial position and market perception.

The Reserve Bank of India has approved the use of biometric payment authentication technology, which is expected to enhance security and convenience in digital transactions. This approval is a significant step for IDEX Biometrics ASA, as it aligns with the company's focus on biometric solutions for secure payments. The move is anticipated to drive adoption of biometric payment systems in India, potentially increasing market opportunities for IDEX Biometrics. The approval by the Reserve Bank of India is likely to significantly enhance market opportunities for biometric payment solutions, impacting IDEX Biometrics' future performance.

IDEX Biometrics ASA has received an order for 45,000 biometric sensor systems from DigAware, which is accelerating its nationwide rollout. This order is expected to enhance IDEX's market presence and support the adoption of biometric technology in various applications. The significant order indicates a major strategic move that could enhance IDEX's competitive position and market dynamics.

IDEX Biometrics ASA has launched a new product portfolio aimed at enhancing payment and access solutions. This portfolio includes advanced biometric technology designed to improve security and user experience in financial transactions and access control systems. The launch is expected to position IDEX Biometrics favorably in the growing market for biometric solutions. The introduction of a new product portfolio is a significant strategic move that could enhance market positioning and investor sentiment.

IDEX Biometrics ASA reported its financial results for the first half of 2025, highlighting key performance metrics and strategic initiatives. The company continues to focus on expanding its biometric solutions in various markets, aiming to enhance user security and convenience. The report outlines revenue growth, product development milestones, and partnerships that are expected to drive future growth. Management expressed optimism about upcoming product launches and market opportunities, positioning the company for a stronger competitive stance. The report indicates significant revenue growth and strategic initiatives that could alter the company's market position.

IDEX Biometrics ASA has registered an increase in share capital as of August 22, 2025. This move is part of the company's ongoing efforts to enhance its financial position and support future growth initiatives. The share capital increase may provide additional resources for operational and strategic initiatives, but its overall impact is expected to be limited.

IDEX Biometrics ASA held an extraordinary general meeting on 14 August 2025, where key decisions regarding the company's future were discussed. Shareholders participated in voting on important matters that could influence the company's strategic direction and operations. The meeting's outcomes may moderately influence the company's strategic direction and operational focus.

SAVYINT has been named the first official technology partner for IDEX Biometrics ASA, focusing on the development of next-generation access cards. This partnership aims to enhance security and user experience through advanced biometric technology, positioning IDEX for growth in the access card market. The partnership with SAVYINT is a significant strategic move that could enhance IDEX's product offerings and market position.

IDEX Biometrics ASA has registered an increase in share capital as of July 29, 2025. This move is part of the company's ongoing efforts to enhance its financial position and support future growth initiatives. The share capital increase may provide additional resources for product development and operational improvements.

IDEX Biometrics ASA announced a private placement of 9,090,909 shares at NOK 3.30 per share, with Tranche 1 comprising 4,731,594 shares. CEO and CFO Anders Storbråten's related company, Pinchcliffe AS, subscribed for 739,360 shares. A share lending agreement was established, with Mr. Storbråten lending 4,731,594 shares for settlement. After these transactions, Mr. Storbråten and close relations hold 6,503,476 shares, representing 12.48% of total outstanding shares. This disclosure complies with EU Market Abuse Regulation and Norwegian Securities Trading Act requirements. The private placement and share lending agreement may moderately influence the company's financial performance and investor sentiment.

IDEX Biometrics ASA successfully completed a fully underwritten private placement, raising NOK 30,000,000 through the issuance of 9,090,909 new shares at NOK 3.30 each. The net proceeds will support the company's commercialization efforts and general corporate purposes. The placement is divided into two tranches, with Tranche 1 already approved and Tranche 2 pending approval at an extraordinary general meeting on 14 August 2025. The company plans to settle the shares on a delivery versus payment basis, with Tranche 1 expected to settle on 24 July 2025 and Tranche 2 on 18 August 2025. The board believes this capital raise aligns with the company's growth strategy and market conditions. The successful capital raise will significantly support IDEX's commercialization efforts and align with its new business strategy.

IDEX Biometrics ASA plans a fully underwritten private placement of 9,090,909 new shares to raise NOK 30 million, with a subscription price of NOK 3.30 per share. The application period starts on 21 July 2025 and may close the same day. The placement will be divided into two tranches, with Tranche 1 consisting of up to 4,731,594 shares and Tranche 2 covering the remainder needed to reach the target amount. Proceeds will support commercialization efforts and general corporate purposes. A subsequent offering for existing shareholders may follow, subject to conditions. The private placement is a significant strategic move to raise capital for commercialization efforts, impacting future financial performance.

IDEX Biometrics ASA is advancing its strategy to become a leading biometric ID company, focusing on ID & Access and Pay sectors. The company has delivered test cards to customers for trials, with positive feedback expected to lead to distribution agreements. IDEX launched the world's first biometric metal card in Bangladesh in July 2025, with promising post-launch activity. A share issue to employees and board members was executed to strengthen commitment to the company's success. Further product launches are anticipated in H2 2025. The launch of the world's first biometric metal card and upcoming product releases are significant strategic moves that could enhance market positioning.

Mastercard has partnered with Eastern Bank PLC and IDEX Biometrics ASA to introduce the world's first biometric metal credit card in Bangladesh. This innovative card features fingerprint authentication technology, enhancing security and convenience for users. The collaboration aims to cater to the growing demand for secure payment solutions in the region, marking a significant milestone in the evolution of payment methods. The launch of a biometric credit card represents a significant strategic move that could enhance IDEX Biometrics' market position and investor sentiment.

IDEX Biometrics ASA has registered a share consolidation (reverse split) effective from July 4, 2025. This move is part of the company's strategy to enhance its stock performance and align with market standards. The share consolidation may moderately influence investor sentiment and stock performance but is not expected to fundamentally alter the company's trajectory.

IDEX Biometrics ASA has registered a share capital increase as of July 1, 2025. This move is part of the company's ongoing efforts to enhance its financial position and support future growth initiatives. The share capital increase may provide necessary funding for operational improvements and growth, but its overall impact is expected to be limited.

IDEX Biometrics ASA announced the issuance of new shares on June 23, 2025, as part of its ongoing capital management strategy. The issuance is expected to support the company's growth initiatives and enhance its financial flexibility. The share issuance may provide necessary capital for growth but is not expected to drastically alter the company's overall trajectory.

IDEX Biometrics ASA announced key information regarding its share consolidation and the subsequent change of its International Securities Identification Number (ISIN). The consolidation aims to enhance the liquidity and marketability of the shares, aligning with the company's strategic objectives. The share consolidation and ISIN change may moderately influence market sentiment and liquidity but are not expected to fundamentally alter the company's trajectory.

IDEX Biometrics ASA has announced a new date for its share consolidation and ISIN change, which is part of its ongoing efforts to enhance its capital structure and improve liquidity. The consolidation is aimed at aligning the company's share price with its strategic objectives and facilitating future growth. Details regarding the new timeline and implications for shareholders have been provided. The share consolidation and ISIN change may moderately influence investor sentiment and liquidity but are not expected to fundamentally alter the company's trajectory.

IDEX Biometrics ASA announced the final results of its Subsequent Offering, which was 8x oversubscribed, allowing the company to allocate and issue 600,000,000 new shares at a price of NOK 0.01 per share, raising gross proceeds of NOK 6 million. The subscription period ran from May 22 to June 5, 2025, with payment due by June 11, 2025. The share capital increase is expected to be registered by June 13, 2025, bringing the total share capital to NOK 44,316,309.99. The new shares will have equal rights with existing shares. Arctic Securities AS is the manager for the offering. The oversubscription and capital raise indicate strong investor interest, which could significantly enhance the company's financial position and market sentiment.

IDEX Biometrics ASA presented its latest developments and strategic initiatives aimed at enhancing its biometric technology offerings. The company highlighted advancements in fingerprint recognition solutions and their applications in various sectors, including payment cards and secure access. IDEX aims to strengthen its market position through partnerships and innovative product launches, addressing growing demand for secure biometric solutions. The presentation also outlined the company's vision for future growth and expansion in the biometric industry. Significant strategic initiatives and product advancements are expected to enhance IDEX's competitive position and market sentiment.

IDEX Biometrics ASA announced the approval of a prospectus by the Financial Supervisory Authority of Norway, allowing for the listing of 3 billion shares from a debt conversion and a subsequent offering of up to 600 million new shares. The subscription period for the subsequent offering will run from May 22 to June 5, 2025. The Debt Conversion Shares will be admitted to trading on Oslo Børs. The prospectus is available electronically and in printed form at the company's office. The approval of the prospectus and subsequent offering represents a significant strategic move that could enhance the company's financial position and market presence.

IDEX Biometrics ASA reported its first quarter results for 2025, highlighting key financial metrics and operational developments. The company continues to focus on expanding its biometric solutions in various markets, aiming to enhance its competitive position. Strategic initiatives and partnerships are emphasized as part of its growth strategy, with a commitment to innovation in biometric technology. The quarterly report indicates moderate progress in financial performance and strategic initiatives that may influence the company's market positioning.

IDEX Biometrics ASA released its annual report for 2024, detailing financial performance, strategic initiatives, and future outlook. The report highlights advancements in biometric technology and partnerships aimed at expanding market reach. Key financial metrics indicate growth, with a focus on innovation and product development to enhance competitive positioning in the biometric sector. The annual report outlines significant strategic initiatives and advancements that could notably influence the company's market position and investor sentiment.

IDEX Biometrics ASA has registered a share capital increase following a debt conversion related to a NOK 30 million loan. The Extraordinary General Meeting approved the issuance of 3,000,000,000 new shares, raising the company's share capital to NOK 38,315,942.32, divided into 3,831,594,232 shares with a nominal value of NOK 0.01 each. The debt conversion and share capital increase may moderately influence the company's financial performance and market positioning.

IDEX Biometrics ASA corrected its previous announcement regarding a large shareholding notice. A close associate of Robert Keith, Charles Street International Ltd., will be allocated 1,000,000,000 shares in a debt conversion, increasing the total shares to 3,831,594,232. This allocation will give Charles Street International Ltd. 26.10% of the shares and voting rights. Robert Keith and his associates will hold 1,087,395,479 shares, representing 28.38% of the company. The shareholding changes may moderately influence investor sentiment and the company's financial performance.

IDEX Biometrics ASA announces that Altea AS will receive 287,500,000 shares in a debt conversion, increasing its total holdings to 354,837,255 shares, representing 9.26% of the company. This follows a resolution at the Extraordinary General Meeting to issue 3,000,000,000 shares, pending registration of a share capital reduction, raising the total number of shares to 3,831,594,232. The disclosure complies with the Norwegian Securities Trading Act. The share issuance and debt conversion may moderately influence the company's financial performance and shareholder structure.

IDEX Biometrics ASA announced the approval of a share consolidation at its Extraordinary General Meeting on 11 April 2025. The consolidation will occur at a ratio of 100 old shares for 1 new share, with the last day to include rights being 10 June 2025. The new ISIN will be NO0013536078, effective from 11 June 2025, replacing the old ISIN NO0013107490. For further inquiries, contact the company's investor relations or CFO. The share consolidation and ISIN change may moderately influence market sentiment and operational aspects but are not expected to fundamentally alter the company's trajectory.

IDEX Biometrics ASA held an extraordinary general meeting on 11 April 2025, with 32.24% of shares represented. All proposed resolutions were passed, including a share capital reduction and a share consolidation of 100 shares into one, expected to take effect around 11 June 2025. Following these changes, the company's share capital will be NOK 38,315,942.32, divided into 3,831,594,232 shares with a nominal value of NOK 0.01. Minutes of the meeting will be available on the company's website. The share consolidation and capital reduction may moderately influence the company's financial performance and market sentiment.